COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis

作者全名:"Fan, Jie; Zhu, Ling; Wu, Xiaohua; Luo, Chunyu; Huang, Ailong; Wang, Wei"

作者地址:"[Fan, Jie; Zhu, Ling; Wang, Wei] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China; [Fan, Jie; Zhu, Ling; Wu, Xiaohua; Luo, Chunyu] Nanan Dist Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Huang, Ailong] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China"

通信作者:"Wang, W (通讯作者),Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China.; Huang, AL (通讯作者),Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China."

来源:FRONTIERS IN PUBLIC HEALTH

ESI学科分类:SOCIAL SCIENCES, GENERAL

WOS号:WOS:001016400500001

JCR分区:Q1

影响因子:5.2

年份:2023

卷号:11

期号: 

开始页: 

结束页: 

文献类型:Article

关键词:COVID-19; vaccine; vaccination experience; adverse events following immunization; mass vaccination center

摘要:"ObjectivesMass vaccination campaigns can rapidly increase the vaccination rate for the COVID-19 vaccine, the establishment of mass vaccination centers is indispensable. At the beginning of March 2021, China began to carry out COVID-19 vaccination activities nationwide. Here, we aimed to evaluate the criteria established by mass vaccination centers, COVID-19 vaccination experience, the incidence of adverse events following immunization and opinions. MethodsWe describe the layout and functioning of Nan'an District mass vaccination center, the working mechanism, experience and effectiveness. Distribution of COVID-19 vaccine vaccination and adverse events following immunization reported in the mass vaccination center of Nan'an District were evaluated. ResultsFrom March 26, 2021 to April 28, 2022, the mass vaccination center has inoculated about 381,364 doses of COVID-19 vaccine to the population. The study found that the incidence of adverse events following immunization (AEFI) was very low (1.04/100000). The chances of having AEFI were significantly higher in COVID-19 vaccine (CHO cell) than COVID-19 vaccine (Vero cell). ConclusionThe mass vaccination center was running successfully. It was effective and safe, providing vaccination services and increasing COVID-19 vaccination rates among the population. The experience of the mass vaccination center for COVID-19 in China can provide a reference for other countries and regions to carry out COVID-19 vaccination."

基金机构: 

基金资助正文: